Digital Health News | pharmaphorum

News

AI drug R&D company Exscientia signs deal with Celgene

UK artificial intelligence (AI) drug discovery company Exscientia has agreed a three year drug discovery deal with Celgene, focusing on finding new cancer and autoimmune drugs.

News

France's Doctolib is new digital health unicorn

Doctolib, the largest digital health service in Europe, has raised 150 million euros in a funding round, valuing it at over a billion euros.

News

Apple Watch shows early promise in AFib diagnosis

A large-scale study has provided some evidence that the Apple Watch could be used to detect atrial fibrillation (AFib) and provide a potentially life-saving early warning for the condition

News

Merck KGaA signs another AI deal

Merck KGaA is doubling down on AI through a new collaboration agreement with tech firm Iktos, using its generative modelling technology to speed up the discovery and design of promising new

News

Study will gauge impact of smartphone on memory and focus

Scientists are to use an app to conduct the first crowdsourcing study on the impact of smartphone use on working memory, mental focus and attention.

News

Survey shows mixed views from patients on smart pills

A new study from Ernst and Young has shown that consumers are driving demand for use of digital health technology – but some are unconvinced about pharma innovations such as smart pills.

AI drug R&D company Exscientia signs deal with Celgene

France's Doctolib is new digital health unicorn

Apple Watch shows early promise in AFib diagnosis

Merck KGaA signs another AI deal

Study will gauge impact of smartphone on memory and focus

Survey shows mixed views from patients on smart pills

GSK to quit Stevenage for new R&D site in Cambridge

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks